Diabetes Topics
The On-Topic Netowork

Diabetes > Creatinine

The following information is about Creatinine.

Creatinine Defined

An end-product of protein metabolism found in the blood and urine, that can be used to help assess if the kidneys are working adequately. A related test, using simultaneous measurements of a timed urine sample plus a blood creatinine test, is called the creatinine clearance.

This definition is in context to Diabetes. See more contextual defintions for Creatinine.


FDA Approves Multaq(R) For Patients With Atrial Fibrillation Or Atrial Flutter

Published July 3, 2009, 5:07 am, Medical News Today

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease.

Full Story


Concerns Over Bisphenol A Continue to Grow

Published July 2, 2009, 12:09 pm, US News & World Report

New studies of plastics chemical measure effects, exposures.

Full Story


Liver Transplantation After Drug Induced Acute Liver Failure Examined By Study

Published July 2, 2009, 9:10 am, Medical News Today

Liver transplantation offers a good chance for survival for patients with drug induced acute liver failure, however, certain pre-transplant factors are associated with worse outcomes. Patients who are on life support, who have elevated serum creatinine, and children whose liver failure was caused by antiepileptic drugs did not fare as well after transplantation.

Full Story


FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter

Published July 2, 2009, 7:46 am, redOrbit

PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets.

Full Story


FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter

Published July 2, 2009, 6:05 am, PR Newswire via Yahoo! Finance

Sanofi-aventis announced today that the U.S. Food and Drug Administration has approved Multaq® 400 mg Tablets. Patients with atrial fibrillation or atrial flutter soon will have a new treatment option to help improve current management of their disease.

Full Story


FDA Approves Multaq(R) for Patients With Atrial Fibrillation or Atrial Flutter

Published July 2, 2009, 1:26 am, FinanzNachrichten

Paris (ots/PRNewswire) - - Multaq(R) Approved to Reduce the Risk of Cardiovascular Hospitalization in Patients With Atrial Fibrillation or Atrial Flutter ...

Full Story


FDA Approves Multaq(R) for Patients With Atrial Fibrillation or Atrial Flutter

Published July 2, 2009, 1:14 am, Presseportal

Paris (ots/PRNewswire) - - Multaq(R) Approved to Reduce the Risk of Cardiovascular Hospitalization in Patients With Atrial Fibrillation or Atrial Flutter - U.S Commercial Launch Planned for the Summer of 2009 ...

Full Story


FDA Approves Multaq(R) for Patients With Atrial Fibrillation or Atrial Flutter

Published July 2, 2009, 1:12 am, ITNews

PARIS, July 2 /PRNewswire/ -- - Multaq(R) Approved to Reduce the Risk of Cardiovascular Hospitalization in Patients With Atrial Fibrillation or Atrial Flutter - U.S Commercial Launch Planned for the Summer of 2009 Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets.

Full Story


Microproteinuria: Indicator to monitor CNI-related nephrotoxicity in liver transplant recipients?

Published June 29, 2009, 6:23 am, EurekAlert!

( World Journal of Gastroenterology ) Calcineurin inhibitor-related renal dysfunction has been widely reported in liver transplant recipients. The monitoring of transplant patients, however, is still dependent on somewhat old indicators: serum creatinine, BUN, total urine output. Microproteinuria is a hallmark of early changes in the glomeruli and proximal tubular function. A research group in ...

Full Story


CHMP Recommends 'Januvia(R)'(sitagliptin), From MSD, For Restricted First Line Use In European Union

Published June 28, 2009, 3:08 am, Medical News Today

Merck & Co., Inc. (Whitehouse Station, N.J., U.S.A.), which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) recommending restricted first line use of 'Januvia' (sitagliptin) for the treatment of type 2 diabetes.

Full Story


Are you looking for additional Diabetes > Creatinine news? Try our new "Creatinine News Focus" area.

Off-site Creatinine Links, User Submitted

The following links have been collected through user bookmark submission in the Creatinine category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Tue Jun 9

Wed Jun 3

Tue Jun 2

Fri May 8

Fri Apr 17

Tue Apr 14

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Creatinine. If you would like to find related tags we recommend Tag Patterns > Creatinine

Off-site Creatinine Research Links

If you still need additional information on Creatinine then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Diabetes

If you know the Diabetes Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Diabetes.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

License

Creative Commons License This work is licensed under Creative Commons.


Your Ad Here
Your Ad Here

Powered by Odin Assemble 2.5a